Lupin launches blood sugar control injection in US

Mumbai-based pharma company Lupin Ltd has launched Liraglutide injection to help control blood sugar in the United States. The injection, available in an 18 mg/3 mL single-patient prefilled pen, is used along…

Novo Nordisk to phase out country’s largest insulin brand

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other older insulin brands in India. Human Mixtard…

USV Joins Empagliflozin generic contest, launches its brand Xenia

New Delhi: One of India’s leading anti-diabetic players, USV, has become the latest entrant in the Empagliflozin generic contest with the launch of its version, Xenia, in India. The Indian drug maker…